Filing Details

Accession Number:
0001209191-23-055563
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-11-16 17:38:18
Reporting Period:
2023-11-15
Accepted Time:
2023-11-16 17:38:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1801777 Applied Molecular Transport Inc. AMTI Pharmaceutical Preparations (2834) 814481426
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1813219 Brandon Hants C/O Applied Molecular Transport Inc.
1209 Orange Street
Wilmington DE 19801
Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-11-15 50,146 $0.16 362,719 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs). This sale satisfies the minimum statutory tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary sale by the Reporting Person.
  2. The price reported in column is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.15 to $0.1748, inclusive. The reporting person undertakes to provide Applied Molecular Transport, Inc., any security holder of Applied Molecular Transport, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. A portion of these securities are RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.